Edwards lifesciences reports q4 eps of $1.32

Edwards lifesciences reports fourth quarter results.q4 adjusted earnings per share $1.46.q4 earnings per share $1.32.q4 sales $1.2 billion versus refinitiv ibes estimate of $1.14 billion.q4 earnings per share estimate $1.49 -- refinitiv ibes data.2020 guidance ranges increased: sales $4.6 billion to $5.0 billion; eps $6.15 to $6.40.qtrly tavr sales of $763 million, a year-over-year increase of approximately 30 percent.for q1 2020, sees total sales to be between $1.15 and $1.2 billion, and adjusted eps of $1.49 to $1.59.fy2020 earnings per share view $6.16, revenue view $4.79 billion -- refinitiv ibes data.q1 earnings per share view $1.50, revenue view $1.14 billion -- refinitiv ibes data.
EW Ratings Summary
EW Quant Ranking